IL143811A - Apparatus and process for preparing crystalline particles - Google Patents
Apparatus and process for preparing crystalline particlesInfo
- Publication number
- IL143811A IL143811A IL14381199A IL14381199A IL143811A IL 143811 A IL143811 A IL 143811A IL 14381199 A IL14381199 A IL 14381199A IL 14381199 A IL14381199 A IL 14381199A IL 143811 A IL143811 A IL 143811A
- Authority
- IL
- Israel
- Prior art keywords
- crystalline particles
- preparing crystalline
- preparing
- particles
- crystalline
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
- B01J2/02—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
- B01D9/005—Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
- B01D9/005—Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
- B01D9/0054—Use of anti-solvent
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
- B01D9/0059—General arrangements of crystallisation plant, e.g. flow sheets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/40—Mixing liquids with liquids; Emulsifying
- B01F23/41—Emulsifying
- B01F23/411—Emulsifying using electrical or magnetic fields, heat or vibrations
- B01F23/4111—Emulsifying using electrical or magnetic fields, heat or vibrations using vibrations
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F31/00—Mixers with shaking, oscillating, or vibrating mechanisms
- B01F31/80—Mixing by means of high-frequency vibrations above one kHz, e.g. ultrasonic vibrations
- B01F31/85—Mixing by means of high-frequency vibrations above one kHz, e.g. ultrasonic vibrations with a vibrating element inside the receptacle
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F33/00—Other mixers; Mixing plants; Combinations of mixers
- B01F33/45—Magnetic mixers; Mixers with magnetically driven stirrers
- B01F33/452—Magnetic mixers; Mixers with magnetically driven stirrers using independent floating stirring elements
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/08—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor
- B01J19/10—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor employing sonic or ultrasonic vibrations
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
- B01J2/18—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic using a vibrating apparatus
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Nozzles (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9828721.2A GB9828721D0 (en) | 1998-12-24 | 1998-12-24 | Novel apparatus and process |
PCT/GB1999/004368 WO2000038811A1 (en) | 1998-12-24 | 1999-12-22 | Apparatus and process for preparing crystalline particles |
Publications (2)
Publication Number | Publication Date |
---|---|
IL143811A0 IL143811A0 (en) | 2002-04-21 |
IL143811A true IL143811A (en) | 2005-06-19 |
Family
ID=10845091
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14381199A IL143811A (en) | 1998-12-24 | 1999-12-22 | Apparatus and process for preparing crystalline particles |
Country Status (19)
Country | Link |
---|---|
US (1) | US6482438B1 (no) |
EP (1) | EP1144065A1 (no) |
JP (1) | JP3588050B2 (no) |
KR (1) | KR20010099933A (no) |
CN (1) | CN1335787A (no) |
AU (1) | AU759880B2 (no) |
BR (1) | BR9916587A (no) |
CA (1) | CA2356897A1 (no) |
CZ (1) | CZ20012331A3 (no) |
GB (1) | GB9828721D0 (no) |
HK (1) | HK1038709A1 (no) |
HU (1) | HUP0104855A3 (no) |
IL (1) | IL143811A (no) |
NO (1) | NO20013039L (no) |
NZ (1) | NZ512400A (no) |
PL (1) | PL349345A1 (no) |
TR (1) | TR200101845T2 (no) |
WO (1) | WO2000038811A1 (no) |
ZA (1) | ZA200105070B (no) |
Families Citing this family (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8123130B2 (en) | 1998-04-17 | 2012-02-28 | Remote Inc. | Remote ordering device |
WO2000061108A1 (en) | 1999-04-14 | 2000-10-19 | Glaxo Group Limited | Pharmaceutical aerosol formulation |
GB0015981D0 (en) * | 2000-06-29 | 2000-08-23 | Glaxo Group Ltd | Novel process for preparing crystalline particles |
GB0016002D0 (en) * | 2000-06-29 | 2000-08-23 | Glaxo Group Ltd | Novel process for preparing crystalline particles |
GB0016040D0 (en) * | 2000-06-29 | 2000-08-23 | Glaxo Group Ltd | Novel process for preparing crystalline particles |
US6787532B2 (en) | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
GB0019172D0 (en) | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
US6777400B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6777399B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
AR032471A1 (es) | 2000-08-05 | 2003-11-12 | Glaxo Group Ltd | Derivado de androstano y solvatos del mismo, su uso para la fabricacion de medicamentos, composiciones farmaceuticas que los comprenden, procesos para preparar tales derivados, intermediarios utiles en la preparacion de tales derivados, procesos para preparar tales intermediarios, y compuestos inter |
US6858596B2 (en) * | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
US6858593B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6750210B2 (en) | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
US6759398B2 (en) | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
FI20002215A0 (fi) * | 2000-10-06 | 2000-10-06 | Orion Yhtymae Oyj | Yhdistelmäpartikkelit |
UA77656C2 (en) | 2001-04-07 | 2007-01-15 | Glaxo Group Ltd | S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent |
CA2445839A1 (en) | 2001-04-30 | 2002-11-07 | Glaxo Group Limited | Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha |
ATE322936T1 (de) * | 2001-05-05 | 2006-04-15 | Accentus Plc | Bildung kleiner krsitalle |
DE10137017A1 (de) | 2001-07-30 | 2003-02-20 | Basf Ag | Kristallisationsverfahren zur Einstellung kleiner Partikel |
CA2458889C (en) * | 2001-08-29 | 2011-06-21 | Dow Global Technologies Inc. | A process for preparing crystalline drug particles by means of precipitation |
GB0125604D0 (en) * | 2001-10-25 | 2001-12-19 | Glaxo Group Ltd | Novel process |
GB0201400D0 (en) * | 2002-01-22 | 2002-03-13 | Glaxo Group Ltd | Novel apparatus and process |
KR20050006201A (ko) * | 2002-04-29 | 2005-01-15 | 브리스톨-마이어스 스큅 컴퍼니 | 아토마이징을 이용하는 결정화 시스템 |
GB0219815D0 (en) * | 2002-08-24 | 2002-10-02 | Accentus Plc | Preparation of small crystals |
GB0212626D0 (en) * | 2002-05-31 | 2002-07-10 | Accentus Plc | Production of crystalline ingredients |
GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
GB0216700D0 (en) | 2002-07-18 | 2002-08-28 | Astrazeneca Ab | Process |
CA2502502C (en) * | 2002-10-17 | 2013-06-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Process for the manufacture of powders of inhalable medicaments |
US20040197275A1 (en) | 2002-10-17 | 2004-10-07 | Ecole Polytechnique Federale De Lausanne | Process for the manufacture of powders of inhalable medicaments |
GB0302673D0 (en) | 2003-02-06 | 2003-03-12 | Astrazeneca Ab | Pharmaceutical formulations |
WO2004073827A1 (en) * | 2003-02-21 | 2004-09-02 | The University Of Bath | Process for the production of particles |
US7638138B2 (en) | 2003-02-21 | 2009-12-29 | Translational Research, Ltd. | Compositions for nasal administration of pharmaceuticals |
CN100404545C (zh) * | 2003-03-27 | 2008-07-23 | 尼科梅德有限责任公司 | 具有规定粒径的结晶环缩松的制备方法 |
MY143936A (en) * | 2003-03-27 | 2011-07-29 | Nycomed Gmbh | Process for preparing crystalline ciclesonide with defined particle size |
CA2519287A1 (en) | 2003-03-27 | 2004-10-14 | Bioactis Limited | Powder medicine applicator for nasal cavity |
SE0302029D0 (sv) * | 2003-07-07 | 2003-07-07 | Astrazeneca Ab | Novel process |
ITMI20032054A1 (it) * | 2003-10-22 | 2005-04-23 | Monteres S R L | Processo per la preparazione di sospensioni farmaceutiche da inalare. |
JP2005177746A (ja) * | 2003-11-28 | 2005-07-07 | Mitsubishi Chemicals Corp | 有機化合物微粒子の製造方法 |
CN1878602A (zh) * | 2003-11-28 | 2006-12-13 | 三菱化学株式会社 | 有机化合物微粒的制造方法 |
WO2006016530A1 (ja) | 2004-08-10 | 2006-02-16 | Translational Research, Ltd. | 速効性でかつ高い吸収性を可能とする経鼻投与用組成物 |
ATE404186T1 (de) * | 2004-10-12 | 2008-08-15 | Generics Uk Ltd | Verfahren zur herstellung von suspensionsaerosolformulierungen, worin die partikel durch präzipition in einem aerosolbehälter gebildet werden |
EP1949891A1 (en) * | 2004-10-12 | 2008-07-30 | Generics (UK) Limited | Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister |
US7314516B2 (en) * | 2004-12-29 | 2008-01-01 | Five Star Technologies, Inc. | Hydrodynamic cavitation crystallization device and process |
ES2613391T3 (es) | 2005-02-10 | 2017-05-24 | Glaxo Group Limited | Procedimientos de fabricación de lactosa que utilizan técnicas de preclasificación y formulaciones farmacéuticas formadas a partir de la misma |
JP2008533055A (ja) * | 2005-03-18 | 2008-08-21 | ナノマテリアルズ テクノロジー ピーティーイー リミテッド | 吸入剤 |
GB0507165D0 (en) * | 2005-04-08 | 2005-05-18 | Glaxo Group Ltd | Novel crystalline pharmaceutical product |
WO2006113309A1 (en) | 2005-04-15 | 2006-10-26 | Dr. Reddy's Laboratories Ltd. | Lacidipine particles |
DE102005053862A1 (de) * | 2005-11-04 | 2007-05-10 | Pharmasol Gmbh | Verfahren und Vorrichtung zur Herstellung hochfeiner Partikel sowie zur Beschichtung solcher Partikel |
FR2897267A1 (fr) * | 2006-02-16 | 2007-08-17 | Flamel Technologies Sa | Formes pharmaceutiques multimicroparticulaires pour administration per os |
GB0610090D0 (en) * | 2006-05-20 | 2006-06-28 | Price Robert | Particulate drug compositions and their uses |
US7811381B2 (en) * | 2006-06-14 | 2010-10-12 | Sirkar Kamalesh K | Antisolvent crystallization in porous hollow fiber devices and methods of use thereof |
EP2044099B1 (en) * | 2006-06-14 | 2012-05-23 | Generics [UK] Limited | Process for the preparation of s-fluoromethyl-6 ,9 -difluoro-11 -hydroxy-16 -methyl-17 -propionyloxy-3-oxo-androsta-1,4-diene-17 -carbothioate and intermediates |
AU2013202835B2 (en) * | 2006-06-14 | 2015-11-12 | Generics [Uk] Limited | Process for the preparation of S-fluoromethyl-6,9-difluoro-11-hydroxy-16-methyl-17-propionyloxy-3-oxo-androsta-1, 4-diene-17-carbothioate and intermediates |
WO2008078730A1 (ja) | 2006-12-26 | 2008-07-03 | Translational Research, Ltd. | 経鼻投与用製剤 |
GB0705159D0 (en) * | 2007-03-19 | 2007-04-25 | Prosonix Ltd | Process for making crystals |
GB0711680D0 (en) * | 2007-06-18 | 2007-07-25 | Prosonix Ltd | Process |
JP2010111592A (ja) * | 2008-11-04 | 2010-05-20 | Aska Pharmaceutical Co Ltd | プロピオン酸フルチカゾンを含む局所投与剤 |
GB0900080D0 (en) * | 2009-01-06 | 2009-02-11 | Prosonix Ltd | An apparatus and process for producing crystals |
DE102009008478A1 (de) | 2009-02-11 | 2010-08-19 | PHAST Gesellschaft für pharmazeutische Qualitätsstandards mbH | Vorrichtung und Verfahren zur Herstellung pharmazeutisch hochfeiner Partikel sowie zur Beschichtung solcher Partikel in Mikroreaktoren |
JP2012526726A (ja) | 2009-05-15 | 2012-11-01 | 株式会社新日本科学 | 薬物動態が改善された鼻腔内用薬学的組成物 |
GB2472327B (en) | 2009-07-31 | 2013-03-13 | Shin Nippon Biomedical Lab Ltd | Intranasal granisetron and nasal applicator |
BR112012011336A2 (pt) | 2009-10-22 | 2018-10-16 | Api Genesis Llc | Composições compreendendo flavonoides, seu método de preparação, adesivo para aplicação de flavonoide, métodos de produção de flavonoide hidratado,métodos de preparação de formulação tópica, e uso de flavonoide |
TR201816320T4 (tr) | 2010-03-22 | 2018-11-21 | Instillo Gmbh | Mikro- veya nanopartikül üretimi işlemi. |
CN101862633B (zh) * | 2010-07-10 | 2012-07-11 | 浙江卫信生物药业有限公司 | 全自动无菌恒温连续流体制剂超声波匀化处理装置 |
JP6151189B2 (ja) | 2010-12-30 | 2017-06-21 | ヤヴァ テクノロジーズ インコーポレイテッドYava Technologies Inc. | 遷移金属化合物粒子および製造方法 |
EP2500072A1 (en) * | 2011-03-15 | 2012-09-19 | LEK Pharmaceuticals d.d. | A novel process of residual solvent removal |
EP2729480A4 (en) * | 2011-07-08 | 2014-12-31 | Pfizer Ltd | PROCESS FOR THE PREPARATION OF FLUTICASONE PROPIONATE, FORM 1 |
US8765725B2 (en) | 2012-05-08 | 2014-07-01 | Aciex Therapeutics, Inc. | Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof |
PT3517541T (pt) * | 2012-05-08 | 2020-08-28 | Nicox Ophthalmics Inc | Forma polimórfica de propionato de fluticasona |
DE102012221219B4 (de) * | 2012-11-20 | 2014-05-28 | Jesalis Pharma Gmbh | Verfahren zur Vergrößerung der Partikelgröße kristalliner Wirkstoff-Mikropartikel |
US9815865B2 (en) | 2013-01-07 | 2017-11-14 | Nicox Ophthalmics, Inc. | Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof |
US9452930B2 (en) * | 2013-11-04 | 2016-09-27 | New Jersey Institute Of Technology | System and method for continuous polymer coating of particles |
CN103977593B (zh) * | 2014-05-19 | 2017-01-04 | 中国工程物理研究院化工材料研究所 | 制备纳米共晶含能材料的方法及装置 |
CN105012237B (zh) * | 2015-08-10 | 2018-09-11 | 重庆华邦制药有限公司 | 糠酸氟替卡松鼻喷雾剂及其制备方法 |
US11744967B2 (en) | 2017-09-26 | 2023-09-05 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal delivery devices |
CN109012260B (zh) * | 2018-09-06 | 2020-10-02 | 董旭 | 一种便于配比的麻醉药物混合器 |
WO2020205539A1 (en) | 2019-03-29 | 2020-10-08 | Vizuri Health Sciences Consumer Healthcare, Inc. | Compositions and methods for the prevention and treatment of radiation dermatitis, eczema, burns, wounds and certain cancers |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL67349C (no) * | 1946-01-16 | |||
DE1262240B (de) | 1964-11-14 | 1968-03-07 | Helmut Pelzer Dipl Chem Dr | Verfahren zur Herstellung feinster Teilchen kristallisierbarer Verbindungen |
DE2504347C3 (de) * | 1975-02-03 | 1978-10-05 | Dso, Pharmachim, Sofia | Verfahren zur Herstellung von reinem Tetracyclinhydrochlorid |
US3979269A (en) | 1975-02-25 | 1976-09-07 | DSO "Pharmachim | Method for obtaining tetracyclinehydrochloride |
JP2843857B2 (ja) * | 1988-10-05 | 1999-01-06 | ファルマシア・アンド・アップジョン・カンパニー | 反溶剤への沈澱を介する微細分化固体結晶性粉末 |
JPH02164712A (ja) | 1988-12-17 | 1990-06-25 | Tosoh Corp | 重炭酸ナトリウムの製造方法 |
GB9005275D0 (en) | 1990-03-09 | 1990-05-02 | Atomic Energy Authority Uk | Crystallization monitor |
JPH0497908A (ja) | 1990-08-10 | 1992-03-30 | Lion Corp | ゼオライトの製造方法 |
AU5171293A (en) | 1992-10-14 | 1994-05-09 | Regents Of The University Of Colorado, The | Ion-pairing of drugs for improved efficacy and delivery |
GB9307225D0 (en) | 1993-04-03 | 1993-05-26 | Atomic Energy Authority Uk | Processing vessel |
US5471001A (en) * | 1994-12-15 | 1995-11-28 | E. I. Du Pont De Nemours And Company | Crystallization of adipic acid |
SE9501384D0 (sv) * | 1995-04-13 | 1995-04-13 | Astra Ab | Process for the preparation of respirable particles |
US5905003A (en) | 1995-06-26 | 1999-05-18 | Energy Conversion Devices, Inc. | Beta to gamma phase cycleable electrochemically active nickel hydroxide material |
GB9624615D0 (en) | 1996-11-26 | 1997-01-15 | Zeneca Ltd | Chrystallisation process |
WO1998033782A1 (en) * | 1997-02-05 | 1998-08-06 | Merck & Co., Inc. | Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent |
GB9826175D0 (en) | 1998-11-28 | 1999-01-20 | Smithkline Beecham Plc | Novel process |
GB9826242D0 (en) | 1998-11-30 | 1999-01-20 | Smithkline Beecham Plc | Novel process |
DE60024982T2 (de) | 1999-01-29 | 2006-07-06 | Bristol-Myers Squibb Co. | Vorrichtung und verfahren zur mit ultraschall beaufschlagten strahlkristallisation |
-
1998
- 1998-12-24 GB GBGB9828721.2A patent/GB9828721D0/en not_active Ceased
-
1999
- 1999-07-07 US US09/348,948 patent/US6482438B1/en not_active Expired - Fee Related
- 1999-12-22 CZ CZ20012331A patent/CZ20012331A3/cs unknown
- 1999-12-22 NZ NZ512400A patent/NZ512400A/xx unknown
- 1999-12-22 JP JP2000590755A patent/JP3588050B2/ja not_active Expired - Fee Related
- 1999-12-22 CA CA002356897A patent/CA2356897A1/en not_active Abandoned
- 1999-12-22 HU HU0104855A patent/HUP0104855A3/hu unknown
- 1999-12-22 IL IL14381199A patent/IL143811A/xx not_active IP Right Cessation
- 1999-12-22 BR BR9916587-2A patent/BR9916587A/pt not_active IP Right Cessation
- 1999-12-22 AU AU18771/00A patent/AU759880B2/en not_active Ceased
- 1999-12-22 WO PCT/GB1999/004368 patent/WO2000038811A1/en not_active Application Discontinuation
- 1999-12-22 EP EP99962413A patent/EP1144065A1/en not_active Ceased
- 1999-12-22 PL PL99349345A patent/PL349345A1/xx unknown
- 1999-12-22 TR TR2001/01845T patent/TR200101845T2/xx unknown
- 1999-12-22 KR KR1020017008081A patent/KR20010099933A/ko active IP Right Grant
- 1999-12-22 CN CN99816326A patent/CN1335787A/zh active Pending
-
2001
- 2001-06-19 NO NO20013039A patent/NO20013039L/no not_active Application Discontinuation
- 2001-06-20 ZA ZA200105070A patent/ZA200105070B/en unknown
-
2002
- 2002-01-09 HK HK02100141.6A patent/HK1038709A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
IL143811A0 (en) | 2002-04-21 |
JP3588050B2 (ja) | 2004-11-10 |
HK1038709A1 (zh) | 2002-03-28 |
NZ512400A (en) | 2003-02-28 |
HUP0104855A3 (en) | 2005-12-28 |
AU1877100A (en) | 2000-07-31 |
NO20013039L (no) | 2001-08-22 |
US6482438B1 (en) | 2002-11-19 |
CA2356897A1 (en) | 2000-07-06 |
EP1144065A1 (en) | 2001-10-17 |
KR20010099933A (ko) | 2001-11-09 |
PL349345A1 (en) | 2002-07-15 |
CZ20012331A3 (cs) | 2002-03-13 |
NO20013039D0 (no) | 2001-06-19 |
HUP0104855A2 (hu) | 2002-04-29 |
BR9916587A (pt) | 2001-09-25 |
ZA200105070B (en) | 2002-09-20 |
TR200101845T2 (tr) | 2001-10-22 |
GB9828721D0 (en) | 1999-02-17 |
AU759880B2 (en) | 2003-05-01 |
WO2000038811A1 (en) | 2000-07-06 |
JP2002533205A (ja) | 2002-10-08 |
CN1335787A (zh) | 2002-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL143811A (en) | Apparatus and process for preparing crystalline particles | |
HUP0203278A3 (en) | Apparatus and process for preparing crystalline particles | |
GB9919230D0 (en) | Process and apparatus for producing (large) packs | |
GB2346133B (en) | Method and apparatus for preparing infant formula from powder | |
HUP9800208A3 (en) | Omega-cycloalkyl-prostaglandin e2-derivatives and process for preparing them | |
CZ20012118A3 (cs) | Způsob výroby 3-alkanoylindolu a 3-alkylindolu | |
HUP9902419A3 (en) | Process for preparing nitrobiphenylene | |
PL372897A1 (en) | Apparatus and process for preparing crystalline particles | |
AU5730500A (en) | Method and apparatus for forming polycrystalline particles | |
HUP0101779A3 (en) | Process for de-chlorinating and de-fouling waste-oil | |
GB2351928B (en) | Process and apparatus for seperating particles | |
GB9808470D0 (en) | Novel process and apparatus | |
EP0916636A4 (en) | METHOD AND DEVICE FOR PRODUCING A COMPOST | |
EP1089978A4 (en) | METHOD FOR PRODUCING OXIMIDAZOLES | |
EG22139A (en) | Process for preparing 4- substituted-1H-indole -3- glyoxamides | |
GB2317178B (en) | Process for preparing 1-chloromethylsilatrane | |
EP1173751A4 (en) | X-RAY GRADOMETERS AND METHODS | |
GB9811225D0 (en) | Methods and apparatus for making appliquÚ items | |
HK1023559A1 (en) | Process for producing dichloroacetoxypropane and derivatives thereof | |
HUP0101730A3 (en) | Method for preparing and using b-starch | |
HUP9701594A3 (en) | Process for producing amines | |
GB0025692D0 (en) | Method and apparatus for adjusting filter | |
GB2339709B (en) | Apparatus for grinding particulate material | |
GB2339165B (en) | Methods and apparatus for particle formation | |
EP1119549A4 (en) | PROCESS FOR THE PREPARATION OF SUBSTITUTED 4-1H-INDOLE-3-GLYOXAMIDES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |